Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
experienced soreness; did not feel well after the first dose; This non-serious case was reported by a nurse via sales rep and described the occurrence of pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included breast cancer (now also recovered from her cancer treatment). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: experienced soreness) and feeling unwell (Verbatim: did not feel well after the first dose). The outcome of the pain and feeling unwell were not reported. It was unknown if the reporter considered the pain and feeling unwell to be related to Shingrix. It was unknown if the company considered the pain and feeling unwell to be related to Shingrix. Additional Information: GSK Receipt Date: 03-APR-2025 The nurse reported that the patient experienced soreness and did not felt well after the first dose of Shingrix vaccine. It was unknow if the symptoms occurred after the second dose. The patient had breast cancer and her physician was treating the cancer suggested she get vaccinated with Shingrix (the cancer was pre-existing before the vaccination). She did completed the 2 dose Shingrix series and the patient was now also recovered from her cancer treatment.
Breast cancer (now also recovered from her cancer treatment)